top space
bottom spacer
  • Painless, rapid, precise skin permeation technology
  • Needle-free continuous glucose monitoring device
  • Needle-free, transdermal drug delivery

Icon   Echo Therapeutics in the News

More >>
05/21/2010 - Echo Therapeutics Needle-Free Symphony™ tC...

Chairman of Echo Therapeutics Scientific Advisory Board, ...


05/17/2010 - Echo Therapeutics Announces First Quarter 20...

Company begins transformative 2010 poised to grow revenue...


Needle-Free Monitoring and Drug Delivery

Echo is developing its PreludeTM SkinPrep System to allow for painless and significantly enhanced skin permeation that will enable both needle-free drug delivery and analyte extraction. Utilizing this technology, Echo is also developing its needle-free SymphonyTM tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system for use in hospital critical care units and for people with diabetes.

Echo Therapeutics: Building a brighter future for diabetes care with
Symphony tCGM